Bone marrow tissue and proliferation markers: Results and general problems
Bone marrow tissue and proliferation markers: Results and general problems
复制标题
骨髓组织和增殖标志物:结果和一般问题
作者:
J. Thiele;R. Fischer
Generally, assessment of cell proliferation may be achieved by a variety of methods amongst which are mitotic count, tritiated thymidine labelling index, bromo-deoxyuridine incorporation, flow cytometry, silverstained nucleolar organizer regions (AgNORs) and immunohistochemistry. For an evaluation of proliferative activity in human tissues which have been processed routinely, the mitotic count is a relatively simple way to measure proliferation. However, the relationships between numbers of mitotic figures and proliferation are not as close as might be expected, because of the great degree of variation in the duration of the different cellcycle phases and the well-known difficulties in discriminating cells in mitosis from pyknotic nuclei or other artefacts (Baak 1990). In addition to AgNORs, several nuclear proteins have been recently identified that are believed to characterize cycling or non-quiescent cells (Brown and Garter 1990; Hall and Levinson 1990; Quinn and Wright 1990; Linden et al. 1992; Yu et al. 1992a; Kreipe etal. 1993a; Schwarting 1993). In the last few years a number of monoclonal antibodies directed against these nuclear proteins have been raised with the aim of determining the proliferative potential of tissue material which has undergone formalin fixation and paraffin-wax embedding, more precisely (Galand and Degraef 1989; Van Dierendonck et al. 1991 ; Cattoretti et al. 1992; Linden et al. 1992; Sawhney and Hall 1992; Kreipe et al. 1993 a; McCormick et al. 1993 a). The possibility of using tissue blocks from files for an estimation of the growth fraction (cells in GI-, S-, G2-, Mphase of cell-cycle) in various malignancies has already been proven to be a very informative adjunct to histology. In this context immunohistological methods involving markers that indicate proliferative capacity seem to
登录
查看更多内容
DOI:
10.1172/jci109989
发表时间:
1980
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
Adamson,JW;Singer,JW;Catalano,P;Murphy,S;Lin,N;Steinmann,L;Ernst,C;Fialkow,PJ
通讯作者:
Fialkow,PJ
DOI:
--
发表时间:
1988
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Nishida,C;Reinhard,P;Linn,S
通讯作者:
Linn,S
影响因子:
3.6
作者:
Andreeff,M
通讯作者:
Andreeff,M
影响因子:
3.3
作者:
Cohen,MB;Waldman,FM;Carroll,PR;Kerschmann,R;Chew,K;Mayall,BH
通讯作者:
Mayall,BH
影响因子:
20.3
作者:
Goto,T;Nishikori,M;Arlin,Z;Gee,T;Kempin,S;Burchenal,J;Strife,A;Wisniewski,D;Lambek,C;Little,C;Jhanwar,S;Chaganti,R;Clarkson,B
通讯作者:
Clarkson,B